Best World

[Boon]

Another "out of stock notice" (not exactly, but soon to be) from BWL Taiwan - seems like sales are still going strong amid the "over exaggerating on product's function" allegation.................  

[Boon]

This documentary programme on BWL Taiwan was aired this morning on Taiwan's tv channel 中天綜合36台 (真心看台灣節目)

Was this a course of action taken in response (not directly though) to Medpartner's allegations ?  

[VIChris]

Hi VIChris,
“失信于民,何以取信于天下...”
It appears to me that your Chinese is pretty good.

I could be wrong, but here is my interpretation.

On the background:

"Over exaggerating on efficacy of product's functions" by distributors" is the original key issue. This was reflected in Medpartner's first article.
How credible were their evidences and supports? I don't know.............

One thing leads to another..............more issues surfaced...........................slandering......defamation.....threaten to sue....etc  

What does it means:

Potentially, risk No:1 could materialise.......................

From page 32 of AR2015: 

The top 5 risks the company faces are identified below: 
1) Advertisements that over promise product efficacy
Distributors sometimes exaggerate the uses of our products, leading to regulatory intervention.Warnings or penalties might be issued to the company, causing reputation damage or monetary losses, affecting our profitability.The company only publishes product attributes that can be supported for each product on our website.Through trainings and interactions, we also remind our distributors not to over exaggerate about the product's efficacy and keep to the proven functions. 
 
________________________________________________________________________________________________________________
 
先別管安麗了你聽過皙之密嗎？瞬間亮白、拉提、碘酒實驗大破解
九月 27, 2016
snow valley
https://www.medpartner.club/bwl-cosmetic...ting-myth/

"特別強調，我們是踢爆全美直銷商的話術跟實驗，在這邊，並沒有特別說全美的產品好或不好，在我沒有全方面徹底研究他的產品前，我不會對這部分評論。大家可以自己去思考相關的問題就好，值不值一個月花15000多元，自己決定就好。全美的直銷商朋友們，不用急著上來崩潰洗版，我真的沒說你們家產品不好，只說你們家有很多不肖直銷商，我說的都有憑有據，大家自己google都是滿滿的這類言論。賣東西很好，賺錢很好，但是真的不用使用唬爛的方式。如果產品真的好，不用這麼唬爛，大家一樣排隊搶著買不是嗎？如果貴公司的人有具體可討論的論點，非常歡迎各種公開討論。但是請不要再跟其他直銷商一樣來攻擊網站或洗版了，真的很沒意義。
 
我們對全美皙之密的要求，跟對NU SKIN還有安麗一樣，你們是一個新加坡上市公司，希望你們承擔起該有的社會責任。我們呼籲全美總公司出來：
1承認錯誤，並公開向受騙的民眾及社會大眾道歉。
2改正錯誤，懲處相關不肖直銷商。
3保證以後不犯，至少要提供「公開、非會員也能服務的檢舉電話」，
讓大家一起來幫你們抓不肖直銷商。這不會是一個趕盡殺絕，而是你們洗白的大好機會。
 
對於認真經營不騙人的直銷商，我們感到很遺憾，希望你們呼籲總公司出來認真面對。對於使用這些唬爛伎倆的直銷商，如果你是不懂，那現在你懂了。但如果你很清楚，那我想跟你分享吳念真說的話：「知識是不是用來掠奪的。」把你的知識用來做更多對社會有益的事情，你不一定會更有錢，但一定會更快樂。...............................................................................................
__________________________________________________________________________________________________________________


Thanks Boon for your background explanation.
Could it be BW sale has been too good and competitors got jealous?
Well, lets see how things developed.

[Boon]

Latest statement from 林政廷:

https://www.facebook.com/bwleb/posts/1134872333233307

本人林政廷近期因事業經營過程有缺失之處造成風波！在此跟大眾及牽連到的朋友致上最大歉意，也謝謝「MEDPARTNER網站」柳林瑋醫生與幕後專業醫美團隊及網友這陣子的糾正與指教，讓我深感經營方式有所不足，未來我會更謹慎言行，在此深深一鞠躬以示感謝！其他尚有爭議事宜全權委託律師處理，並且尊重司法。
事發後而許多朋友問我為什麼傳統產業不是做的好好的，幹嘛要來經營直銷這「敏感」的行業呢？還搞到上新聞！老實說會經營全美真的我這輩子沒有想到，也從來沒有後悔！自從我跟我老婆投入美睫事業打拼至今已有八年之久，從一開始六坪車庫改造的工作室做到現在小有規模的美睫公司，這八年我們幫許多人接睫毛，也培訓許多學生創業，學生創業後也跟我們買產品或加盟，所以我們夫妻結識不少愛美的朋友，其中許多從創業時期一路支持我們到現在的美睫店和美睫師，她們從一個人工作室變成好幾人的店面，還很多開了分店，彼此的感情更像是老戰友一樣，時常關心彼此與閒話家常。
這幾年因大環境景氣不佳及店家削價競爭，許多美睫店家都紛紛開始尋求複合式經營來增加收入，結合美甲、美容或紋繡，或進些保養品在店裡銷售，也很多投入直銷經營，身為廠商的我，有時他們來拜訪跟我推銷時，也會盡量做個人情捧個場，多少消費一下，安X，艾X美，W旅遊，多X瑞，美X佳我都曾經購買過，產品本質有的真的不錯，但是因為我對直銷沒興趣，也覺得賺不到錢，所以從來不曾經營！
但在去年十月在網路上看到一位屏東學員兼美睫師 珊珊，在FB推廣「皙之密」保養品，每次都見她在臉書PO上自己的美照，述說產品好用來推廣分享，那時心想「她可能美睫業績不好，需要靠副業來維持」，秉持幫助年輕人創業的精神，又對這組網路上號稱媲美醫美的產品有些許好奇心，於是乎請她帶來我們公司跟我介紹，來了之後她一直說它是一套檢驗合格絕對沒問題的產品（心想誰會說自己產品不好，SGS花錢就有啊，應該是話術！），後來幫我體驗洗臉後用布說可以「暫時拉提」，其實我不以為然，覺得是老王賣瓜自賣自誇罷了！後來她還一支支保養介紹，其實那時覺得很浪費我時間，我一個企業老闆，真的沒空與耐心仔細聽完，我只是好奇想了解，聽到又是直銷也沒興趣，最後也怕她煩著拉我當下線，那我決定就買一組2萬多元來幫助年輕人吧。
以為捧場後就沒事了，沒想到過沒幾天她又聯絡我說，特地請來最高階的一位男生『易霖經理』來為我說明，希望透過完善專業的講解，讓我感受到與傳統直銷與眾不同的地方，心想慘了遇上詐騙集團，這肯定是俗稱『洗腦洗下線』，不要騙我第一天出社會啦！一定會叫我買更多貨來升位階！但是礙於情面，也不得不讓她們來，於是來了之後從產品到制度通通講完一輪，再到談到自己靠一套可以複製的課程系統，慢慢打造團隊業績一個月幾千萬，而他今年才36歲，而且是黑手的背景(修車工人)講到這…我想說騙肖A！修車工人轉業直銷後能那麼厲害！根本是「講古」！等不及他講完就開門見山問：「既然你說業績這麼多，你敢不敢直接給我看相關業績憑證？對於我這個突然的要求，對方也十分大方的打開自己的全美公司經銷商後台系統，把每個月團隊業績明細，一條條讓我看得清楚，看到十月份業績高達8000萬！他說全美比上年度成長100%以上，而我當時的美睫業績跟上年度相比確下滑20%，到這裡我真的已經動搖了，心想可能有機會可以彌補本業的下滑業績，這時有預感要被說服了，加上全美的制度只要不到二萬元買一套基礎保養產品就能擁有經營權，商品聽起來很有效果，看他們二個一男一女的皮膚都不錯，即使經營不起來就當自己擦，或者送給員工當尾牙禮物，完全沒有風險，再經詢問制度方面也無需每月強制囤貨，每年最低只要有消費一條洗面乳就能自動續會員資格，心想這樣來跟我的配合店家推廣肯定推的動，如果有人願意加入，可能又多一筆「被動」收入，於是二話不說決定背著也討厭直銷的老婆，先斬後奏，小心翼翼繳了身份證件加入會員，開始投身經營人生第一份直銷工作。
但是我還是不放心直銷的產品與公司，整個十一月我都沒有推廣，也沒有貨可以使用，因為那時十一月週年慶大缺貨！所以我花了一個月時間研究產品效能與公司背景，我開始上網查所有關於「皙之密」的評價想來了解該產品，發現皙之密的製造企業-全美公司位在律法嚴謹的新加坡，公司市值80億，不但背景和評價相當好，更是新加坡第一家上市直銷公司。雖然經營直銷我是排斥的事情，但如果被跟大眾一樣對直銷先入為主的想法箝制，是不是也有可能錯過好機會？故研究一個月後，向來對於商機眼光精準的我，也明顯感覺到手上這套「皙之密」保養品非常有潛力，於是我再花了一筆錢自行抽驗「皙之密」其中的幾瓶，報告結果成份都安全沒問題，於是十二月我決定不顧他人的眼光與家人的反對，正式經營我人生第一份直銷事業，對於身為第一次做直銷的直銷菜鳥的我，幸好有所屬體系各12縣市的免費課程提供我與店家進修，還有體系學姐學長的互相幫忙，讓我很快的就慢慢進入狀況，也剛好自己台北與台南公司又有場地空間，就這樣，我們透過舉辦說明會來讓同樣對「全美事業」有興趣的朋友了解，從一開始的一場稀稀疏疏10幾人，到後期有口碑後一場最多50多人前來參加，很多美睫店家們聽完都和我一樣覺得這是一個可以嘗試經營的機會，也基於我多年的信譽二話不說而加入！因為產品效果好，回購率高，就這樣沒幾個月很快的「皙之密」和「全美世界公司」就在台灣的美睫業打響知名度，業績也瞬間爆發，我也這樣跟著受益升到公司體系裡的最高位階「PD鉑階企業經理」，而且打破全美二十多年紀錄。
打破紀錄的當下讓我覺得非常得意，加上原本不相信「皙之密」的老婆袁健菊雖然長期靠打雷射保養好幾年了，但生完三胎後還是擋不住出現一些皮膚狀況，像這次我提到的斑，更是讓她困擾！而她看到許多夥伴親身使用後的皮膚見證，讓她也好奇試試看，結果用了七個月與雷射雙管齊下後真的改善很多，於是她慢慢成為一位愛用者，但這次讓她被捲入風波，還被許多網友指指點點與批評謾駡，看到她坐在床邊默默的看著網友的留言與新聞難過流淚，讓我感到非常的愧疚與心痛！這裡我要聲明，文是我發的，圖是我傳的，有任何責任由我負責，真的與她無關！
這段期間為了讓業績更好，我利用迅速竄紅的名氣與之前做美睫打下來的底子，開始四處高調造勢與宣傳自己成功的直銷事業，也把老婆的前後見證照當廣告，相信也是這次被大眾拿放大鏡檢視的主因，甚至連藝人許維恩也被牽連，我在此用生命發誓，許維恩真的沒有投資，經營，加入，甚至使用「皙之密」，她可能知道我有賣保養品，但是她真的不清楚那是什麼！就像我知道她有經營服飾，飾品，保養品，但我也不清楚她的品牌與如何運作一般！
但我公司在許維恩代言美睫期間，將其肖像用於一張美睫與皙之密放在一起的優惠文宣，已經違反合約精神，並牽連影響形象，對這件事我們公司已經登報跟維恩致歉，並且為了彌補維恩形象的受損，與短期內工作受影響的損失，我把我沙龍店面股份無條件過戶，並且再負擔後續部份的人事薪資與店租成本，最後將已經裝潢好的台北公司門市也遷移至他處營業，以確保維恩清白，也希望這家她一手打造的店，不要受到此次風波影響，而埋葬了維恩開店的夢想！也謝謝維恩事發至今，沒有一句責備，她用寬容待人，她用理性處理，讓我深感敬佩與窩心，再次謝謝她。
俗話說樹大招風，事業越成功，關注的眼光也更多！尤其是直銷這種敏感的行業。這件事主要起因還是我在經營事業與平時生活上太高調且未謹慎言行，讓我這次付出相當大的代價！這點我已經深深的檢討與虛心領教，未來會把自己的經驗與知識，在每一場聚會及課程上，在實體與網路上好好的做正確教育與自我把關，讓直銷產業不再讓人以偏概全，被帶有色眼光看待！
而我已經加入全美一年了，這一年我參加了超過五十場聚會與課程，認識了數以千計的直銷人，慢慢的我從以前對直銷「矯情虛偽」「不務正業」「昂貴無用」的刻板印象變成「真心熱情」「正當行業」「合理有效」的感同身受！我很愛自己的愛美公司與員工，因為他們逆轉我的人生，也愛全美公司與夥伴，因為他們點燃我的熱情，所以這件事有錯我來負責，請大家不要因為我的事件風波，就否定前輩們數年來的努力與打造出的品牌形象。
為了提昇更好的直銷教育，成為更好的領導者，除了在九月底已經上完直銷法學院課程（內容為化妝品相關法令與直銷公平交易法），更於規劃十一月加入直銷公會成為會員為直銷業盡心力，十月底起我也會利用聚會與活動，在會場上分享這次事件的經驗，並傳達正確的經營法令觀念與如何有效不失真的推廣，屆時對「皙之密保養品」或「全美事業」有疑慮或有興趣的朋友都可以報名參加，當然對我有任何指教的朋友，也歡迎蒞臨參加提出，或者網路私訊我告知，您們的聲音就是我改進的動力，謝謝大家！
愛美時尚美睫公司總監
全美世界鉑階企業經理
林政廷 2016.10.25發稿
_____________________________________________________________________________________________________________________________________

[chialc88]

http://www.valuebuddies.com/thread-3961-...#pid132273

Good morning, Valuebuddies.

What's keeping Dora and Doreen awake at night?

If you're still wondering, that means you had missed the past few blogs from Boon completely.
Basically, it happened.
BWL distributors exaggerated the use of it's products and was pointed out by a blogger (who also dig out other direct sells company bad practises besides BWL).
If you watch the video recorded by BWL distributors and you will laugh (especially if you're not a major  shareholder).
Anyone with some science background can see thru the *magic* trick or effects of BWL products.

You know, those 30 years old tricks that is still practise today...
really laugh until big teeth drop.

Anyway, the blogger use the right words, Xiang Ming (villagers, Kampong people) really fall for the tricks.
(with great entertainment values too).

Code:

Distributors sometimes exaggerate the uses of our products.
We remind our distributors not to over exaggerate about the product's efficacy
and keep to the proven functions.

And, of course, the main actor/hero to resue the situation (who is a BWL PD) 
       {What? you don't know what is  PD stands for? ai yo... go google find out and tell us.}
Anyway, the hero 本人林政廷, follow the script and provided a very convincing model answer.

What's going to happen next?
Not sure.

What's going to happen to BWL result? 
... Announcing 4th Nov 2016 after 5pm?

For those vested, you got to decide to sell, to buy or to hold on.

For those not vested, I think the logical way is to buy on the dip.
(on 2nd thought, is it too late already?)

nvm, enjoy a happy Diwali.

 Love Compassion

[namralk]

This incident reflected the challenges ahead of Best World. Looking at the comments of medpartner, many commentors do not use BW products but still gave negative feedbacks just because they associate direct sales = bad.

Direct sales distributors are partners of the company, they are not salary-drawing staff. It is a challenge trying to "control" how the distributors sell and represent the products when the number of distributors increases exponentially. Setting the right culture, topline leading downline to sell the products to end users (not pull in downline as priority), continue to make sure products is of top quality, are essential to set in place before chionging China. I would imagine that it would be even more challenging to "control" the China distributors.

[chialc88]

Good morning valuebuddies.

First, sit up and enjoy a highly charge up BWL Songs.
Yes, BWL has a company songs.

Code:

亞洲先鋒 Pioneering Asia

---

CF asked what differentiate BWL from the rest of direct selling/MLM company.

Actually not much different.

I only hope and I have faith that Dora learned enough and had the wisdom to do the right things.

In tonight SGX result announcement,
we have 2 winners:


 
 Love Compassion

[Boon]

3Q2016/9M2016 results (Released on 04-Nov-2016)
 
Group Revenue (SGD Million)
1Q2014 =  12.802     (= 17% of FY2014 Revenue)
2Q2014 =  18.278     (= 24% of FY2014 Revenue)
3Q2014 =  19.229     (= 26% of FY2014 Revenue)
4Q2014 =  24.957     (= 33% of FY2014 Revenue) FY2014  =  75.226
1Q2015 =  13.507     (= 13% of FY2015 Revenue)
2Q2015 =  21.029     (= 21% of FY2015 Revenue)
3Q2015 =  26.191     (= 26% of FY2015 Revenue)
4Q2015 =  40.945     (= 40% of FY2015 Revenue) FY2015 = 101.672
1Q2016 =  35.226     
2Q2016 =  51.568    
3Q2016 =  52.253     (+ 1.3% only compared to 2Q2016, a new quarterly record, nevertheless)
9M2016 =  138.947    (New 9M revenue record)
 
3Q>2Q>1Q still holds for 2016 - but only “just” - as 3Q beats 2Q only by a slim margin.
Is this sign of “peaking”?
Will 4Q beat 3Q? Will see……
 
GPM / NPM
1Q2014 = 74.0% / 0.9%
2Q2014 = 69.8% / 4.1%
3Q2014 = 75.5% / 5.8%
4Q2014 = 77.1% / 8.2%
FY2014  = 74.4% / 5.4%
1Q2015 = 74.9% / 1.8%
2Q2015 = 75.8% /10.0%
3Q2015 = 77.1% /15.4%
4Q2015 = 74.8% / 9.1%
FY2015 =  75.6% / 9.9%
1Q2016 = 75.5% /16.9%
2Q2016 = 74.8% /14.3%
3Q2016 = 71.6% /17.1%
9M2016 = 73.8% /16.0%
 
GPM dipped (still managed to stay above the 70% mark), but interestingly NPM improved. Why?
3Q2016 NPM of 17.1% looks impressive, so is 9M2016 NPM of 16%.
 
NPAT / EPS
1Q2014 = 0.121 m / 0.06 cent
2Q2014 = 0.758 m / 0.34 cent
3Q2014 = 1.123 m / 0.51 cent
4Q2014 = 2.052 m / 0.93 cent (FY2014  = 4.054 m / 1.86 cent)
1Q2015 = 0.249 m / 0.11 cent
2Q2015 = 2.106 m / 0.96 cent
3Q2015 = 4.035 m / 1.83 cent
4Q2015 = 3.714 m / 1.69 cent  (FY2015 =10.104 m / 4.59 cent)
1Q2016 = 5.963 m / 2.71 cent
2Q2016 = 7.369 m / 3.35 cent
3Q2016 = 8.933 m / 4.06 cent (pre-bonus) or 3.25 cent (post-bonus) - (new quarterly NPAT/EPS record) : (+ 21%, compared to 2Q2016)
9M2016 =22.265 m / 10.11 cent (pre-bonus) or 8.09 cent (post-bonus) - (new 9M NPAT/EPS record)
 
9M2016 NPAT of 22.265 m is already more than doubled that of FY2015 NPAT of 10.104 m; 9M2016 EPS of 10.11 cents (pre-bonus) is already more than doubled that of FY2015 EPS of 4.59 cents – driven both by increase in revenue and the much improved NPM. 
 
OCF (before change in working capital and before tax):
3Q2016 = 14.521 m
9M2016 = 33.764 m
 
OCF (After change in working capital and after tax):
3Q2016 = -1.041 m
9M2016 =  1.281 m
 
Impressive cash generative business but a lot of working capital is also being needed to support the current growth – hence not much left after change in working capital and after tax.
 
Taiwan Revenue (SGD million)
1Q2014 =   2.418   (= 11% of FY2014 Revenue)
2Q2014 =   4.157   (= 18% of FY2014 Revenue)
3Q2014 =   4.940   (= 22% of FY2014 Revenue)
4Q2014 = 11.196   (= 49% of FY2014 Revenue) ;(FY2014  = 22.711)
1Q2015 = 4.465     (=   8% of FY2015 Revenue)
2Q2015 = 10.244   (= 18% of FY2015 Revenue)
3Q2015 = 14.125   (=  25% of FY2015 Revenue)
4Q2015 = 27.559   (=  49% of FY2015 Revenue) ;(FY2015  = 56.393)
1Q2016 = 20.221  
2Q2016 = 35.056  
3Q2016 = 27.602   (- 21.2% compared to 2Q2016)
9M2016 = 82.879   (New 9M record)
 
3Q>2Q>1Q no longer holds for Taiwan in 2016. Is this sign of “peaking”?
 
China Revenue (SGD million) = Export Revenue + MW Revenue:
1Q2014 =  2.195
2Q2014 =  3.296
3Q2014 =  3.117
4Q2014 =  4.372  (FY2014  =12.980)
1Q2015 =  3.088
2Q2015 =  5.366
3Q2015 =  4.805
4Q2015 =  6.512  (FY2015  =19.771)
1Q2016 =10.566  (Export = 9.609 ; MW= 0.957)
2Q2016 =11.813  (Export =10.777 ;MW =1.036)
3Q2016 =19.641  (Export =18.563 ; MW=1.078) ; (+72% compared to 2Q2016, Export)
9M2016 =42.020  (Export =38.949 ;MW =3.071)
 
9M2016 China revenue of 42.020 m (predominantly under Export model) is more than double that of FY2015 revenue of 19.771 m.
 
______________________________________________
 
1)   3Q2016 group revenue is only 1.3% better than 2Q2016 ~ or close to flat. Slack in Taiwan (-21.2% in DS) is being taken up by increased export sales to China (+72%).
2)   GPM is higher in “DS” but lower in “export sales”, whereas NPM is higher in “export sales” but lower in “DS”. Higher proportion mix of “export sales” decreased overall GPM but increased overall NPM. This explains why, despite of near flat revenue, 3Q2016 NPAT/EPS improved (+21%) as compared to 2Q2016.
3)   Lots of working capital is needed to fund the current growth, which fortunately could be met by cash generated from the business itself.
4)   FY2016 is going to be a record breaking year in many respects, regardless of how good or how bad 4Q 2016 results turn our to be (have to be profitable of course).
5)   It appears that the ONLY growth market in 3Q2016 is China.
6)   Big question remains: “Has Taiwan revenue peaked?”
__________________________________________________________________________________________   

[Boon]

[Image: xq9lk2.jpg]

Supply must be able to keep up in a timely manner to satisfy increasing demand - More investment in working capital is needed, beside capital investment in the Tuas factory.


[Image: 2nkkjtu.jpg]


The ONLY growth market in 3Q2016 is China. Taiwan seemed to have lost a bit of momentum on quarterly basis. On yearly basis, Taiwan is still looking fine.
 
FY2016 has been shaping up to be a record-breaking year.

Looking beyond and into FY2017, if Taiwan could not keep up with its growth momentum, China would be counted upon to make up for Taiwan’s revenue “deficit” in order to avoid slipping back into negative growth at group level, as other markets don’t seem to be growing.  
_______________________________________________________________________________________________________

[Boon]

http://infopub.sgx.com/FileOpen/2016%201...eID=428786

RESPONSE TO SGX-ST QUERY ON RESULTS ANNOUNCEMENT FOR THE FINANCIAL PERIOD ENDED 30 SEPTEMBER 2016 
__________________________________________________________________________________________________________________________________________________